Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Novogene Co., Ltd.
  6. Summary
    688315   CNE1000052X3

NOVOGENE CO., LTD.

(688315)
  Report
End-of-day quote Shanghai Stock Exchange  -  2022-11-24
26.54 CNY   -2.25%
10/24Novogene Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
09/07Novogene America Unveils Superpowered Robot Scientist for Autonomously Intelligent NGS Delivery- Falcon II
CI
08/10Novogene Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
11/21/2022 11/22/2022 11/23/2022 11/24/2022 11/25/2022 Date
28.27 27.3 26.5 27.15 26.54 Last
1163328 1541224 759736 841495 719008 Volume
-0.60% -3.43% -2.93% +2.45% -2.25% Change
Estimated financial data (e)
Sales 2022 2 505 M 349 M 349 M
Net income 2022 303 M 42,3 M 42,3 M
Net Debt 2022 - - -
P/E ratio 2022 34,9x
Yield 2022 -
Sales 2023 3 431 M 478 M 478 M
Net income 2023 408 M 56,9 M 56,9 M
Net Debt 2023 - - -
P/E ratio 2023 26,0x
Yield 2023 -
Capitalization 10 621 M 1 481 M 1 481 M
Capi. / Sales 2022 4,24x
Capi. / Sales 2023 3,10x
Nbr of Employees 2 169
Free-Float 19,6%
More Financials
Company
Novogene Co Ltd is a China-based company mainly engaged in gene sequencing. The Company mainly relies on high-throughput sequencing technology and bioinformatics analysis technology to establish gene sequencing platforms. Combined with multi-omics research technology, the Company provides multi-level scientific and research technical services and solutions for life science basic research, medical and clinical... 
More about the company
Ratings of Novogene Co., Ltd.
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about NOVOGENE CO., LTD.
10/24Novogene Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 202..
CI
09/07Novogene America Unveils Superpowered Robot Scientist for Autonomously Intelligent NGS ..
CI
08/10Novogene Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
07/07Philrivers announced that it has received $15 million in funding from Insight Venture M..
CI
06/13Novogene Co., Ltd.(SHSE:688315) added to Shanghai Stock Exchange..
CI
04/26Novogene Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/18Novogene Co., Ltd.(SHSE:688315) added to Shanghai Stock Exchange..
CI
04/13Certain A Shares of Novogene Co., Ltd. are subject to a Lock-Up Agreement Ending on 13-..
CI
04/13Novogene Co., Ltd.(SHSE:688315) added to Shanghai Stock Exchange..
CI
04/08Novogene Co., Ltd. announced that it expects to receive CNY 2.27307 billion in funding
CI
02/24Novogene Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
2021Novogene Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 202..
CI
2018Beijing Novogene Technology Co. Ltd. cancelled the acquisition of 10 Sequel Systems, so..
CI
2017Pacific Biosciences of California, Inc. and Novogene Corporation to Jointly Develop and..
CI
2017Beijing Novogene Technology Co. Ltd. agreed to acquire 10 Sequel™ Systems, so-Seq&..
CI
More news
News in other languages on NOVOGENE CO., LTD.
10/24Novogene Co., Ltd. annonce ses résultats pour les neuf mois se terminant le 30 septembr..
09/07Novogene America dévoile un robot scientifique surpuissant pour la livraison autonome e..
08/10Novogene Co., Ltd. annonce ses résultats pour le semestre clos le 30 juin 2022
04/26Novogene Co., Ltd. annonce ses résultats pour le premier trimestre clos le 31 mars 2022
02/24Novogene Co., Ltd. annonce ses résultats pour l'année complète se terminant le 31 décem..
More news
Chart NOVOGENE CO., LTD.
Duration : Period :
Novogene Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 26,54 CNY
Average target price 28,89 CNY
Spread / Average Target 8,85%
EPS Revisions
Managers and Directors
Rui Qiang Li Chairman & General Manager
Jia Shan Shi Chief Financial Officer
Li Hua Zhao Chairman-Supervisory Board
Ran Zhang Independent Director
Jin Ling Li Member-Supervisory Board
Sector and Competitors